Available data from the Mount Sinai Brain Bank, also showed increase FMNL2 expression in the parahippocampal gyrus (p = 0.0004) in pathological AD, and in data from the Mayo Clinical Brain Bank, FMNL2 expression was increased in the temporal cortex (p = 0.011) in pathological AD (Table 3). This evidence concerns the gene FMNL2 and Alzheimer disease.